PARAGON CARE LIMITED (PGC)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
![](/stocklogo/PGC.jpg)
PGC - PARAGON CARE LIMITED
FNArena Sector :
Medical Equipment & Devices
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 3.33
Index:
FNArena Sector : Medical Equipment & Devices
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 3.33
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$0.46
25 Jul |
OPEN $0.45 |
HIGH $0.46 |
769,582 LOW $0.44 |
TARGET | |||||
|
|||||
Franking for last dividend paid out: 100% |
OTHER COMPANIES IN THE SAME SECTOR | |||
4DX . AT1 . BB1 . BRN . CAT . CBL . CGS . CMP . COH . CSX . CU6 . CYC . EBR . EMV . EYE . FPH . IDX . IME . IMR . IPD . LDX . MX1 . NAN . ONE . PCK . PEB . PME . RMD . SOM . TRJ . UBI . VTI . |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY22 Actual |
FY23 Actual |
FY24 Forecast |
FY25 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | 1.6 | 2.1 | xxx |
DPS (cps) | xxx | 1.2 | 0.0 | xxx |
EPS Growth | xxx | 12.3% | 28.0% | xxx |
DPS Growth | xxx | 0.0% | N/A | xxx |
PE Ratio | xxx | N/A | 21.4 | xxx |
Dividend Yield | xxx | N/A | 0.0% | xxx |
Div Pay Ratio(%) | xxx | 73.2% | N/A | xxx |
Last ex-div: 18/09 - ex-div 0.6c (franking 100%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | 1.6 |
DPS All | xxx | xxx | xxx | xxx | xxx | 1.2 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 307.6 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 36.8 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | 17.7 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | 4.18 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | 5.37 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | 3.76 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | 2.90 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | 5.37 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | 7.06 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | -10.9 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 22 M |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | 100 M |
Total Debt | xxx | xxx | xxx | xxx | xxx | 122 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | 326 M |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 23 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | 0.64 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | 21.0 M |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 6.84 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 256 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 25 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | - |
Investments - Total | xxx | xxx | xxx | xxx | xxx | 2 M |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
![](/images/chart-unavailable.png)
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
EXTRA COVERAGE
Display All Commentary
No. Of Recommendations
Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.
PGC STOCK CHART
![](/wp-content/uploads/2020/10/img-side-banner-stock-analysis.jpg)
FNArena News on PGC
1 |
‘Defensive’ Pharmaceutical Wholesalers In FocusJul 18 2024 - Australia |
2 |
FNArena Corporate Results Monitor – 31-08-2023Aug 31 2023 - Australia |
3 |
Weekly Ratings, Targets, Forecast Changes – 28-07-23Jul 31 2023 - Weekly Reports |
4 |
Australian Broker Call *Extra* Edition – Mar 06, 2023Mar 06 2023 - Daily Market Reports |
5 |
Australian Broker Call *Extra* Edition – Sep 21, 2022Sep 21 2022 - Daily Market Reports |
Latest Medical Equipment & Devices News
1 |
Dr Boreham’s Crucible: BlinklabMay 20 2024 - Small Caps |
2 |
ResMed Silences The DoubtersApr 29 2024 - Australia |
3 |
Dr Boreham’s Crucible: 4D MedicalApr 23 2024 - Small Caps |
4 |
Uptrend Resumed For ResMedMar 19 2024 - Technicals |
5 |
Dr Boreham’s Crucible: CochlearFeb 28 2024 - Australia |
6 |
Rudi Interviewed: Ongoing Potential In Technology & GrowthFeb 19 2024 - Rudi's View |
7 |
Dr Boreham’s Crucible: ArtryaFeb 15 2024 - Small Caps |
8 |
ResMed Recovery Turns Into Hollywood ScriptJan 31 2024 - Australia |
9 |
ResMed Makes A ComebackJan 29 2024 - Australia |
10 |
ResMed: The Recovery Has BegunJan 23 2024 - Technicals |